Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.720
-0.390 (-9.49%)
At close: May 15, 2026, 4:00 PM EDT
3.780
+0.060 (1.61%)
After-hours: May 15, 2026, 6:39 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $222.76 million as of May 15, 2026. Its market cap has increased by 110.98% in one year.
Market Cap
222.76M
Enterprise Value
144.20M
1-Year Change
110.98%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since May 17, 2021, Orchestra BioMed Holdings's market cap has increased from $209.00M to $222.76M, an increase of 6.58%. That is a compound annual growth rate of 1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 233.33B | -10.36% |
| Dec 31, 2025 | 260.30B | 170,092.87% |
| Dec 31, 2024 | 152.94M | -53.18% |
| Dec 29, 2023 | 326.65M | 40.47% |
| Dec 30, 2022 | 232.55M | 12.81% |
| Dec 31, 2021 | 206.14M | -1.37% |
| May 17, 2021 | 209.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 250.75M |
| Fate Therapeutics | 248.85M |
| Cartesian Therapeutics | 247.39M |
| Foghorn Therapeutics | 244.84M |
| Adagene | 244.47M |
| Whitehawk Therapeutics | 243.68M |
| Minerva Neurosciences | 243.32M |
| Sol-Gel Technologies | 238.80M |